UK markets closed

Claritas Pharmaceuticals, Inc. (CLAZF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0001+0.0001 (+9,900.00%)
As of 09:52AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
Total revenue
0
0
Operating expenses
Research development
-
-2,055
Selling general and administrative
1,570
1,871
Total operating expenses
-485
-184
Operating income or loss
485
184
Interest expense
768
225
Total other income/expenses net
-
-587
Income before tax
-3,079
-674
Income tax expense
-4,884
-4,884
Income from continuing operations
1,805
4,210
Net income
-4,718
4,210
Net income available to common shareholders
-4,718
4,210
Basic EPS
-0.13
0.16
Diluted EPS
-0.13
0.16
Basic average shares
30,967
26,691
Diluted average shares
30,967
26,691